chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia
Clinical narrative: "Pins and needles" sensation on the left side of neck; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 11May2021 at 09:15 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included cetirizine hydrochloride (ZYRTEC) and ibuprofen (ADVIL) and over the counter (otc) sleep aid (unspecified); all on unknown dates for unknown indications and unknown if ongoing. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 20Apr2021 at 09:30 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. On 11May2021 at 10:15, roughly 20 minutes after the vaccine, the patient started feeling a "pins and needles" sensation on the left side of neck, then began to feel it on left arm. After that, the sensation spread to various other parts of the body. The patient felt the sensation every few minutes for a couple seconds at a time. As of 18:27, the patient still felt it and called doctor and she asked to come in for an appointment, during which she gave a physical exam. She did not find any other adverse effects and she told to monitor the symptoms, report them to Pfizer (she said she would do the same), and that she would call the next day. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event "pins and needles" sensation on the left side of neck was not resolved at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Parosmia
Clinical narrative: Change in smell, metallic; smell similar to spray type deodorant.; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 04May2021 at 08:15 (at the age of 49-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medication was not reported. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. The patient previously received erythromycin (MANUFACTURER UNKNOWN) for unspecified indication from unknown date and experienced drug allergy. The patient previously received first dose (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0162) via an unspecified route of administration in the right arm on 13Apr2021 at 08:00 (at the age of 49-years-old), as a single dose for COVID-19 immunisation. On 06May2021, the patient experienced change in smell, metallic; a smell similar to spray type deodorant. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event change in smell, metallic was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Vision blurred, Vitreous floaters
Clinical narrative: Blurry vision; Spot/floaters right eye; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0161) via an unspecified route of administration in the left arm on 16Apr2021 at 12:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any other medications within two weeks prior to the vaccination. On 18Apr2021, the patient experienced blurry vision and spot/floaters in right eye. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events blurry vision and spot/floaters right eye were recovered with sequelae on an unknown date in 2021.   No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia
Clinical narrative: Fatigue; Fever; pain; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 16Apr2021 at 12:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not take concomitant medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On an unknown date in 2021 the patient experienced fatigue, fever and pain. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fatigue, fever and pain was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Pain in extremity, Peripheral swelling
Clinical narrative: Pain and swelling for over two weeks now.; Pain and swelling for over two weeks now.; Difficulty using right arm; This is a spontaneous report from a contactable consumer, the patient. A 68-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep8731) via an unspecified route of administration in the right arm on 22Apr2021 at 10:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any vaccination within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7533) via an unspecified route of administration in the left arm on 01Apr2021 at 10:00 (at the age of 68-years-old) as a single dose for COVID-19 immunisation. On 24Apr2021 at 00:00, the patient experienced pain and swelling for over two weeks at the time of the report. The patient also experienced difficulty using right arm. The adverse events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events pain and swelling for over two weeks now, difficulty using right arm was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Joint swelling, Swelling, Vaccination site pain
Clinical narrative: Pain in arm where shot is; Above collar bone severely swollen; Above wrist swollen; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EW0158) via an unspecified route of administration in the arm on 26Apr2021 at 12:45 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. Patient had no medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 28Apr2021 at 00:00, the patient experienced pain in arm where shot was administered, and also reported severe swelling above collar bone and swelling on top above wrist. No therapeutic measures were taken as a result of the reported events. Since the vaccination the patient had not been tested for COVID-19. The clinical outcome of the events of pain in arm where shot, above collar bone severely swollen and top above wrist swollen was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Tinnitus
Clinical narrative: Chills 7 days after second dose; Followed by ringing/heartbeat sound in left ear which has persisted; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the right arm on 29Apr2021 at 14:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfur and penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any other medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the right arm on 08Apr2021 at 14:00 as a single dose for COVID-19 immunisation. On 06May2021 at 18:00, the patient experienced chills 7 days after second dose followed by ringing/heartbeat sound in left ear which had persisted. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills 7 days after second dose followed by ringing/heartbeat sound in left ear which had persisted, were not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 22.0
Sex: M
Vaccine: COVID19
Symptoms: Blister, Pruritus, Rash
Clinical narrative: rash developed in its place; Blisters worsen & spread across both arms, increase in itchiness and discomfort; Blisters observed all over right and left hand; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 23Apr2021 at 11:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patients relevant medical history and concomitant medications were not reported. The patients known allergies to medications, food or other products was not applicable. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 02Apr2021 at 11:30 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 28Apr2021, the patient experienced blisters all over right and left hand. On 02May2021, the blisters worsened and spread across both arms, increase in itchiness and discomfort. On 03May2021, the patient was prescribed 6-day unspecified steroids plan to start: 4mg each, 6 pill/day with tapering down of 1 pill/day. On 10May2021,unspecified steroids helped reduce blisters, a rash developed in its place. On 11May2021, additional unspecified steroids were prescribed to help with the rash, started 40mg per day for 4 days, 30mg per day for 4 days, 20mg per day for 4 days and 10mg per day for 4 days. The events did result in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events blisters, itchiness and rash were resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Sensory loss
Clinical narrative: Numb sensation came over entire body; face, arm and leg remained feelingpartially numb for the next 24 hours.; Right side of my face had a numb sensation; Felt like loosing the sensation.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the right arm on 21Apr2021 at 11:30 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history included human leukocyte antigen (HLA-B27) positive (creates inflammation issues), iritis (outer iris eye inflammation), bell's palsy (the patient never had a stroke but have had bell's palsy in 2009 which took 3 months to recover) and stress. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included ethinylestradiol, ferrous fumarate, norethisterone acetate (MICROGESTIN FE 1/20), bupropion (MANUFACTURER UNKNOWN) and escitalopram (MANUFACTURER UNKNOWN); all were from unknown date and for unspecified indication. The patient previously took CECLOR on an unknown date for unspecified indication and experienced drug allergy. On 21Apr2021 at 11:45, fifteen minutes after the vaccine, the patient experienced right arm (injection side) and right side of face numb sensation, could feel the temperature of fingers and pinches on arm and face but felt like she was losing the sensation. It almost felt like the patient were to have a stroke. The feeling she had on face was exactly how bell's palsy felt initially, but then again, she was able to move all her muscles and feel. Twenty minutes after the vaccine, the numb sensation came over entire body. This lasted about 1 minute and then resided however, the right side of face, arm and leg remained feeling partially numb for the next 24 hours. Due to this scary reaction, the patient stated that she would not be taking the second vaccine, until more information is released on its connection to nerve inflammation, bell's palsy and the proteins the vaccine uses. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as the result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events right arm (injection side) and right side of face numb sensation, could feel the temperature of fingers and pinches on arm and face but felt like she was losing the sensation, face, arm and leg remained feeling partially numb , the numb sensation came over entire body were recovered on 22Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 15:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to food (pumpkin seed allergy) and allergy to nuts (almond allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications.  On an unknown date in 2021, the patient experienced shingles. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of shingles which included treatment with antibiotics. The clinical outcome of the event shingles was not recovered at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles on penis.  Appears to be minor (two bright red bumps with a bit of swelling under skin); This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 06May2021 at 11:30 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 15Apr2021 at 11:30 (at the age of 37-years-old), as a single dose for COVID-19 immunisation. On 11May2021 at 11:00, the patient experienced shingles on penis (two bright red bumps with a bit of swelling under skin). Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event shingles on penis (two bright red bumps with a bit of swelling under skin) was not recovered at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Malaise, Tremor, Visual impairment
Clinical narrative: My vision went dark and I could not see the desk in front of me; My head went backward and hit thewall behind me.; I was shaking uncontrollably, I continued to shake uncontrollable for a total of about 30 minutes; continued to feel very weak and shake.; I continued to feel very weak; I was not doing well; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received an BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Pfizer ER8739) via an unspecified route of administration on 24Apr2021 at 09:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19.The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24Apr2021 at 09:15, while patient was siting in chair waiting the 15 minutes, the patient experienced that the vision went dark and could not see the desk in front of her, the head went backward and hit the wall behind her and was shaking uncontrollably. The patient continued to shake uncontrollably for a total of about 30 minutes and felt very scared. The patient had some water but was not doing well and after patient left facility, continued to feel very weak and shake. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events- the vision went dark and she could not see the desk in front of her, the head went backward and hit the wall behind her and was shaking uncontrollably, continued to shake uncontrollably, was not doing well and continued to feel very weak and shake was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Bone pain, Bone swelling, Hypokinesia
Clinical narrative: Swelling in armpit with tennis ball size mass; Swelling on collar bone with a small ball size mass that rolls; Swelling in neck; Tender feeling; Awkward pain under arm; Shoulder pain; Collar bone pain; Neck pain; Soreness in arm; Could not raise arm above shoulder; Awkward pain radiating along back of arm, down to elbow and fingers, through the muscle in back and into the spine, also to the collar bone and into the neck; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the right arm on 08May2021 at 11:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 17Apr2021 at 10:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient previously also received ibuprofen (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASPIRIN) for unknown indications and experienced drugs allergy. On 10May2021, second day after vaccine, the patient experienced soreness in arm, could not raise above shoulder. Awkward pain radiating along back of arm, down to elbow and fingers, through the muscle in her back and into her spine, also to her collar bone and into her neck. On 11May2021, on the third day, the patient was able to lift her arm over her head and also experienced awkward pain under arm, shoulder, collar bone, and neck. On 12May2021, day 4, the patient had same pain and noticed swelling in armpit with tennis ball size mass, swelling on collar bone with a small ball size mass that rolls, and swelling in neck. Pain was moderate but more of an awkward and tender feeling. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events soreness in arm, could not raise above shoulder, awkward pain radiating along back of arm, down to elbow and fingers, through the muscle in back and into the spine, also to the collar bone and into the neck, awkward pain under arm, shoulder pain, Collar bone pain, neck pain, swelling in armpit with tennis ball size mass, swelling on collar bone with a small ball size mass that rolls, swelling in neck and tender feeling were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain, Pain, Pain in extremity, Swelling, Tenderness
Clinical narrative: Swelling in armpit with tennis ball size mass; Swelling on collar bone with a small ball size mass that rolls; Swelling in neck; Tender feeling; Awkward pain under arm; Shoulder pain; Collar bone pain; Neck pain; Soreness in arm; Could not raise arm above shoulder; Awkward pain radiating along back of arm, down to elbow and fingers, through the muscle in back and into the spine, also to the collar bone and into the neck; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the right arm on 08May2021 at 11:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 17Apr2021 at 10:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient previously also received ibuprofen (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASPIRIN) for unknown indications and experienced drugs allergy. On 10May2021, second day after vaccine, the patient experienced soreness in arm, could not raise above shoulder. Awkward pain radiating along back of arm, down to elbow and fingers, through the muscle in her back and into her spine, also to her collar bone and into her neck. On 11May2021, on the third day, the patient was able to lift her arm over her head and also experienced awkward pain under arm, shoulder, collar bone, and neck. On 12May2021, day 4, the patient had same pain and noticed swelling in armpit with tennis ball size mass, swelling on collar bone with a small ball size mass that rolls, and swelling in neck. Pain was moderate but more of an awkward and tender feeling. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events soreness in arm, could not raise above shoulder, awkward pain radiating along back of arm, down to elbow and fingers, through the muscle in back and into the spine, also to the collar bone and into the neck, awkward pain under arm, shoulder pain, Collar bone pain, neck pain, swelling in armpit with tennis ball size mass, swelling on collar bone with a small ball size mass that rolls, swelling in neck and tender feeling were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Inflammation, Joint swelling
Clinical narrative: I have pain and swelling in the joints of my fingers.; I have pain and swelling in the joints of my fingers.; Inflammation in the sole of both feet; Backside of the knee hurts; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm right on 04Apr2021 at 14:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. Allergies to medications, food or other products was reported as not that the patient knows of. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the arm left on 14Mar2021 at 14:30 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021 at 14:00, the patient experienced pain and swelling in the joints of the fingers. The patient also had inflammation in the sole of both feet and backside of the knee hurts. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event pain and swelling in the joints of the fingers, inflammation in the sole of both feet and backside of the knee hurts were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Paraesthesia, Pruritus, Sensation of foreign body
Clinical narrative: Tingling sensation in  upper lip all the way down to upper chest./ had giggling bf in hands and knee caps; I had a feeling of a lump stuck in my throat.; Burning sensation on right side on abdomen; Itching feeling on left arm near elbow but not for long; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ERS731) via an unspecified route of administration in the arm right on 10May2021 at 17:30 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine and allergy to tree nuts.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG201) via an unspecified route of administration in the right arm on 19Apr2021 at 15:30 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. On 10May2021 at 17:45, the patient experienced tingling sensation in upper lip all the way down to upper chest, lump stuck in throat, burning sensation on right side of the abdomen. The patient had itching feeling on the left arm near elbow but not for long. The patient had giggling bf in hands and knee caps. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were taken as a result of the events which included treatment with dexamethasone (MANUFACTURER UNKNOWN) and diphenhydramine (BENADRYL).  The clinical outcome of the events of tingling sensation in upper lip all the way down to upper chest, lump stuck in throat, burning sensation on right side abdomen, itching feeling on left arm near elbow but not for long and giggling bf in hands and knee caps were recovered on an unknown date in May2021.   No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Lymphadenopathy, Nausea
Clinical narrative: Swollen, red, hot patch around injection site; Swollen, red, hot patch around injection site; Swollen, red, hot patch around injection site; Swollen lymph node in armpit; Arm hurt all the way down to finger tips; Nausea; Headache; Fatigue; Joint pain; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 08May2021 at 11:45 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. Medical history included diabetes and unspecified allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 11Apr2021 at 11:45 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08May2021 at 18:00, the patient experienced swollen, red, hot patch around injection site, swollen lymph node in armpit, arm hurt all the way down to finger tips, nausea, headache, fatigue, and joint pain. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events swollen, red, hot patch around injection site, swollen lymph node in armpit, arm hurt all the way down to finger tips, nausea, headache, fatigue, and joint pain were not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Swollen, red, hot patch around injection site; Swollen, red, hot patch around injection site; Swollen, red, hot patch around injection site; Swollen lymph node in armpit; Arm hurt all the way down to finger tips; Nausea; Headache; Fatigue; Joint pain; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0182) via an unspecified route of administration in the left arm on 08May2021 at 11:45 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. Medical history included diabetes and unspecified allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 11Apr2021 at 11:45 (at the age of 45-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08May2021 at 18:00, the patient experienced swollen, red, hot patch around injection site, swollen lymph node in armpit, arm hurt all the way down to finger tips, nausea, headache, fatigue, and joint pain. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events swollen, red, hot patch around injection site, swollen lymph node in armpit, arm hurt all the way down to finger tips, nausea, headache, fatigue, and joint pain were not recovered at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal distension, Arthralgia, SARS-CoV-2 test, Vertigo positional, Weight increased
Clinical narrative: Pain in left hip, knee and ankle; Upper abdominal bloating; Weight gain; Positional Vertigo; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old, non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 26Mar2021 at 14:00 (at the age of 63-year-old) as single dose for COVID-19 immunisation. Medical history included allergy. Concomitant medication included colecalciferol (VITAMIN D3) for unknown indication from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 26Feb2021 at 14:00 (at the age of 63-year-old) as single dose for COVID-19 immunisation. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 29Mar2021, the patient experienced pain in left hip, knee, and ankle, upper abdominal bloating, weight gain and positional vertigo. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On an unknown date, the patient underwent COVID-19 Nasal swab test and the result was negative. The clinical outcome of the events of pain in left hip, knee, and ankle, upper abdominal bloating, weight gain and positional vertigo were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Induration, Pain in extremity, Swelling
Clinical narrative: Arm pain; Swelling with induration of; Swelling with induration of; This is a spontaneous report from a contactable physician. A 63-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0168) via an unspecified route of administration in the left arm on 06May2021 at 13:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included morbid obesity, hypertension (HTN), diabetes mellitus (DM), multinodular goiter and hypothyroid. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID -19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN), metformin (MANUFACTURER UNKNOWN), salbutamol (VENTOLIN), lisinopril (MANUFACTURER UNKNOWN), vitamin d (MANUFACTURER UNKNOWN), vitamin b complex (MANUFACTURER UNKNOWN) and montelukast (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing.  On 06May2021, the patient experienced arm pain and swelling with induration of. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of arm pain and swelling with induration of. The clinical outcome of the events arm pain and swelling with induration of were resolved with sequelae (also reported as resolved with lasting effects) on an unknown date in May2021.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Pyrexia, Vomiting
Clinical narrative: Fever; Fatigue; Vomiting; Dizziness; This is a spontaneous report from a non-contactable consumer. A female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 09May2021, as a single dose for COVID-19 immunisation. It was unknown whether the patient was pregnant at the time of vaccination. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was unknown whether the patient receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunisation. On 10May2021, the patient experienced fever, fatigue, dizziness and vomiting. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of fever, fatigue, dizziness and vomiting which included treatment with paracetamol (TYLENOL). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, fatigue, dizziness and vomiting were resolved on an unspecified date in May2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Chills; Fever; Body aches; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the right arm on 08May2021 at 10:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history included undifferentiated connective tissue disease, osteoporosis, controlled nonfamilial obstructive sleep apnea syndrome and aortic valve replacement. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received unspecified concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the right arm on 17Apr2021 at 10:00 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. The patient previously also received paracetamol; oxycodone hydrochloride (PERCOCET), simvastatin (MANUFACTURER UNKNOWN) and naproxen (NAPROXIN) and experienced drug allergy. On 09May2021 at 15:00, the patient experienced chills, fever and body aches. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, fever and body aches was recovered on an unknown date in May2021.  No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dizziness, Fatigue
Clinical narrative: Mild dizziness; Mild pressure in my mid-chest (2 out of 10 in discomfort, felt like a bearing down/pressure, not a pain); Mild fatigued; This is a spontaneous report from a contactable healthcare professional, the patient. A 49-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route in the left arm on 21Apr2021 at 10:00 (at the age of 49-years-old) as single dose for COVID-19 immunisation. Medical history included allergy to adhesive. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccination within four weeks of COVID vaccine. Concomitant medications included ascorbic acid (ESTER C) and colecalciferol (VITAMIN D3); both for unknown indication from unknown date and unknown if ongoing. The patient previously received tetracycline and experienced drug allergy. On 21Apr2021 at 10:15, the patient experienced mild dizziness within first 15 minutes of vaccine and mild pressure in mid-chest (2 out of 10 in discomfort, felt like a bearing down/pressure, not a pain). These lasted for several days (approximately five days), but did not worsen. The patient experienced no other symptoms other than mild fatigued. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events of mild dizziness and mild pressure in mid-chest (2 out of 10 in discomfort, felt like a bearing down/pressure, not a pain) was resolved on an unknown date Apr2021; while that of the event of mild fatigued was resolved on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Tremor
Clinical narrative: Woke up with chills, entire body began to shake violently and uncontrollably for about an hour; Woke up with chills, entire body began to shake violently and uncontrollably for about an hour.; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO176) via an unspecified route of administration in the left arm on 11May2021 at 12:30 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, chronic pain and COVID-19 on an unknown date and unknown if ongoing. The patient had no known allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included mirtazapine (MANUFACTURER UNKNOWN), beclometasone dipropionate (QVAR), salbutamol (VENTOLIN), paracetamol (TYLENOL), acetylsalicylic acid (ASPIRIN) and Adv; all for unknown indication from unknown date and unknown if ongoing. On 12May2021 at 03:30, the patient woke up with chills, entire body began to shake violently and uncontrollably for about an hour. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events woke up with chills, entire body began to shake violently and uncontrollably for about an hour was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Malaise
Clinical narrative: Headache; Chills; Fatigue; Malaise; This is a spontaneous report from a contactable nurse. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 10May2021 at 18:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 11May2021, the patient experienced headache, chills, fatigue and malaise. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the reported adverse events and included treatment with ibuprofen. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event headache, chills, fatigue and malaise was unknown at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.